Allstate Investment Management’s Gilead Sciences GILD Stock Holding History

Allstate Investment Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$4M	Buy	+46,546	New	+$3.69M	0.12%	116

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Allstate Investment Management's GILD Position: Q4 2022 in Review

Allstate Investment Management opened a new position in Gilead Sciences (GILD) in Q4 2022: 46,546 shares worth $4M. The stake represents 0.12% of the portfolio and ranks #116 among its holdings.

1,768 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

Allstate Investment Management held 46,546 shares of Gilead Sciences worth $4M as of Q4 2022.
Gilead Sciences was a new Allstate Investment Management position in Q4 2022.
Gilead Sciences made up 0.12% of Allstate Investment Management's portfolio in Q4 2022, its #116 holding.
1,768 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Allstate Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.